Center Ventures | Pharmaceutical

About

Our Story Honorary President Company Timeline Leadership Consultants
Business Segments

Investment

Strategy Portfolio

Pharmaceutical
ESG

Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
Investors

Overview Financial Information Shareholder’s Services Corporate Governance FAQ
News
Careers

Job Openings
Contact

繁體中文

Pharmaceutical

Center Laboratory Inc.

continues to develop diverse oral medical solutions and has gained an excellent reputation in the industry. In the future, we will continue to enhance our competitiveness and strive to become the most professional oral liquid pharmaceutical company, a leader in the CNS field, and an expert in special drug development and the biotech industry.

Our pharmaceutical portfolio is anchored by two strategic pillars: Specialized CNS Therapies and Comprehensive Primary Care (Non-CNS). Together, these two pillars enable us to address critical medical needs, ranging from chronic neurological disorders to common acute illnesses.

CNS

Parkinson's disease, PD: Rakinson
Dementia: Rivast, Manotin, Memary, Lizepen
Depression: CenZoft, Talopram
Schizophrenia: Seridol, ApraZ, QTING
Epilepsy: Sodium Valproate, Remaltin, Levotam
Cerebrovascular diseases: Piracetam

Non-CNS

Antipyretic Analgesics: ANTI-PHEN, IBUPROFEN, NAPOTIN
Bronchodilators: ALBUTEROL, STROLIN, CENTERTHEO, EXDILA, CENFENOL
Anti-inflammatory agents: Kidsolone
Antihistamines: CETIRIZINE, CYPROMIN, ATHMIN, ORNADIN, ACTIN
Expectorants: MUCO, CASTEINE, SOLTAN, GUAPHEN
Narcotic Antitussives & Expectorants: DINCO, CONSRINE, Compound Glycyrrhiza Mixture, Liquid Brown Mixture, COMPOUND GLYCYRRHIZA MIXTURE, Lin Cough Liq
Non-narcotic Antitussives & Expectorants: SECORINE, Doxycough, SORTUSS, BUTAMIRATE, MIRATE, SUTUSSI
Gastrointestinal Agents: Simethicone, LECOTIN, WEMPTY, ASWELL
Others: LEUCOMYCIN, SULFACOTRIM, CARDIACIN

Our Cultural Prospective

Care

we are committed to the development of innovative medications, the improvement of a patients’ quality of life, to the improvement of the quality of medicine and to the continuous commitment to the discussion and betterment of government policy. We aim to interconnect the resources and development ability of industry, government, and academia to promote an excellent and healthy industry environment.

Integrity

we are value-oriented; with sincere, respectful, and reciprocal attitudes towards our customers, building long and sustainable partnerships via professional interactions and continuous learning.

Professionalism

we are focusing on the development of excellence in the industry and specialize in accessing the knowledge of target fields. With strong ambitions and excellent teamwork, we aim to become leaders in the field. Through the talent program, we are trained to commit to our professional heritage.

Innovation

In between reality and our ideal goal, we utilize rational thinking and creativity to maintain existing achievements and implement a pragmatic future, creating new milestones.

Research And Development

Center Laboratories Inc., specializing in manufacturing oral medication, is dedicated to the development of diverse liquid drugs/products. Through advanced technology platform integration, professional prescription research, and prescription design analysis, we invent 3 – 5 new products annually; thus, able to continue in strengthening our innovation and competitiveness.

We have successfully overcome the challenge of the bitter taste in oral medicine while solving the difficulties of maintaining the stability and solubility of drugs in solution. In new drug development connecting special medication for infants and young children, we analyzed the causes of the struggle in the administration struggle and the difficulties in potency adjustment. We continue developing oral medication on respiratory tract, gastrointestinal tract, central nervous system, and cardiovascular system. In addition, we are also developing medications for common diseases in children (such as asthma and allergy, etc.) and rare diseases. We are courageously resolving the challenges in maintaining the solubility and stability of poor-soluble drug in a liquid state, and continuously developing new formulation drugs that currently unmet prescriptions need.

Manufacturing And Marketing

We are continuously improving factory requirement which already meet the highest national standards of PIC/S specification. From the perspective of customers, we constantly enhance the packaging and labels. Consistent operating procedures and an excellent professional marketing team with extensive knowledge of products to provide exclusive services to customers, we have completed a market layout of hospitals and clinics nationally. Furthermore, the collaboration between logistics systems has improved the annual production, which has since reached 24 million bottles of oral medication and 60% of market share in Taiwan.

Looking Into The Future

Striving For Perfection

Center Laboratories Inc. is the largest oral liquid medication pharmaceutical company in Taiwan. In the short term, we are committed to the development of CNS liquid medication, a special drug portfolio, brand development, patient care, disease management, and product licensing out.
Cross-Striate Cooperation

Incorporating the investment of Center Laboratories Inc. in China, Univision Pharmaceutical Co., LTD; completing cross-striate CNS special drug portfolio, establishing communication of clinical regularity and trade distribution, and accelerating market authorization and development; thus, we are creating the overall effectiveness of drug products of Center Laboratories Inc. in both Taiwan and China. We aim to become a cross-strait brand image of the best pharmaceutical in the CNS field and the best partner in cross-strait marketing for global/foreign pharmaceutical companies. We are establishing and promoting the adjusted personalized drug models by defining the optimal dosage and strengthen drug product portfolio and brand image. In the future, we hope to establish leadership in the CNS field and expand this successful experience across Asia.
Global Vision

Center Laboratories Inc. intends to be the most professional oral liquid medication and the leader in CNS drugs in Asia. From this base to integrating various resources of R&D, clinical, regulatory, production, and marketing, thus strengthening the development of personalized/region-specific drug products, leading Center Laboratories Inc. not only as the leader in oral liquid medication and CNS drugs, but also as the expert in differentiated/personalized drugs.